Viewing Study NCT02651168


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-31 @ 1:15 AM
Study NCT ID: NCT02651168
Status: UNKNOWN
Last Update Posted: 2016-01-08
First Post: 2016-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
Sponsor: Unity Health Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module